Today Challenge is the only independently owned, exclusively pharmaceutical printer to accomplish "critical mass". This combination of laser-like focus and wide market reach has fueled our dramatic growth and has helped us become the de facto choice of pharmaceutical manufacturers.
Our responsiveness to customers' needs is enhanced through the use of a secure, electronic network, which connects our facilities and delivers valuable feedback from the manufacturing floor on a real-time basis.
Through the formation of an Urgent Response Team (URT), we are able to complete new product launches for our customers within 24 hours or less.
Our approach to Quality is simple: doing it right the first time, every time. Our Quality Group is a separate entity, with an independent reporting structure.
The Challenge Printing Company has the equipment and capacity necessary to handle the upcoming serialization demands on the pharmaceutical industry. Because of our focus on exclusively pharmaceutical printing we have prepared for the 2015 California serialization deadline through extensive planning